AstraZeneca injects £120m into UK site

Drugs giant AstraZeneca is to invest £120 million in a new facility at its global manufacturing site in the UK, securing 300 jobs and creating 200 temporary posts.

The development, at the firm's plant in Macclesfield, Cheshire, will lead to continued production of Zoladex, an injectable treatment for patients with prostate cancer.
%VIRTUAL-SkimlinksPromo%